Welcome to the Windy City and the 12th International Kidney Cancer Symposium!

We are delighted to have you with us and hope that you will find the Symposium productive and informative. This special event would not have been possible without the many hours of hard work by the Scientific Program Committee – E. Jason Abel, M.D., Toni K. Choueiri, M.D., James H. Finke, Ph.D., Jorge A. Garcia, M.D., FACP, R. Houston Thompson, M.D., and W. Kimryn Rathmell, M.D. They have put together a comprehensive program that is both informative, and will provide a basis for your continued work in kidney cancer. This year’s symposium also includes a very timely session on immunotherapy, endorsed by the Society for Immunotherapy of Cancer.

Since 1990, the Kidney Cancer Association has dedicated itself to the eradication of kidney cancer and to improving care, stimulating research, and increasing survival of kidney cancer patients worldwide. We are the only organization of its kind to serve kidney cancer patients, their families, and physicians around the world. As we work to globalize our organization, we hope to continue our collaboration with you so that we may be of further assistance to you and your patients.

Please note that as part of our commitment to environmental responsibility, this year’s presentations and abstracts will be online. Information on how to access these materials can be found in your book. Your comments are welcome.

Thank you again for joining us for the 12th International Kidney Cancer Symposium. If there is anything we can do to help you during the next two days, please do not hesitate to call on us.

Signature 1

Ronald M. Bukowski, M.D.
Chair, Board of Directors
Kidney Cancer Association

William P. Bro
CEO
Kidney Cancer Association


Signature 2

James H. Finke, PhD
Board of Directors
Society for Immunotherapy of Cancer

Tara Withington, CAE
Executive Director
Society for Immunotherapy of Cancer